Results
1 -
7 of
7
(Click
here to explore results)
- FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms. Baku Acharya, Debasmita Saha, Daniel Armstrong, Naga Rajiv Lakkaniga, Brendan Frett
, RSC Med. Chem.
, 2022
, 13
, 798
- Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules. Baku Acharya, Debasmita Saha, Daniel Armstrong, Baha'a Jabali, Maha Hanafi, Alan Herrera-Rueda, Naga Rajiv Lakkaniga, Brendan Frett
, RSC Med. Chem.
, 2024
, 15
, 399
- Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6. Alexandria M. Chan, Steven Fletcher
, RSC Med. Chem.
, 2021
, 12
, 178
- Integration of pharmacophore mapping and molecular docking in sequential virtual screening: towards the discovery of novel JAK2 inhibitors. Ting-Ting Yao, Jiang-Feng Xie, Xing-Guo Liu, Jing-Li Cheng, Cheng-Yuan Zhu, Jin-Hao Zhao, Xiao-Wu Dong
, RSC Adv.
, 2017
, 7
, 10353
- Next-generation of selective histone deacetylase inhibitors. Feifei Yang, Na Zhao, Di Ge, Yihua Chen
, RSC Adv.
, 2019
, 9
, 19571
- Importance and synthesis of benzannulated medium-sized and macrocyclic rings (BMRs). Altaf Hussain, S. K. Yousuf, Debaraj Mukherjee
, RSC Adv.
, 2014
, 4
, 43241
- Defining and navigating macrocycle chemical space. Lauren A. Viarengo-Baker, Lauren E. Brown, Anna A. Rzepiela, Adrian Whitty
, Chem. Sci.
, 2021
, 12
, 4309